Shanghai Xuerong Biotechnology Co.,Ltd. (SHE:300511)
China
· Delayed Price · Currency is CNY 7.37
-0.09 (-1.21%)
At close: Mar 9, 2026
SHE:300511 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 4,723 | 1,731 | 2,668 | 3,245 | 3,350 | 5,768 | Upgrade
|
| Market Cap Growth | 182.64% | -35.13% | -17.76% | -3.14% | -41.93% | 98.51% | Upgrade
|
| Enterprise Value | 5,872 | 3,771 | 4,380 | 4,520 | 5,066 | 6,913 | Upgrade
|
| Last Close Price | 7.37 | 3.47 | 5.35 | 6.45 | 7.58 | 12.87 | Upgrade
|
| PE Ratio | - | - | - | - | - | 25.04 | Upgrade
|
| Forward PE | - | 8.61 | 13.05 | 7.90 | 8.42 | 16.15 | Upgrade
|
| PS Ratio | 2.56 | 0.80 | 1.04 | 1.40 | 1.62 | 2.62 | Upgrade
|
| PB Ratio | 3.50 | 2.10 | 1.86 | 2.00 | 2.03 | 2.88 | Upgrade
|
| P/TBV Ratio | 4.06 | 2.71 | 2.14 | 2.13 | 2.50 | 3.28 | Upgrade
|
| P/FCF Ratio | 12.87 | 15.77 | - | 68.08 | - | 79.37 | Upgrade
|
| P/OCF Ratio | 10.48 | 3.96 | 7.46 | 8.84 | 13.73 | 10.39 | Upgrade
|
| EV/Sales Ratio | 3.18 | 1.74 | 1.71 | 1.95 | 2.44 | 3.14 | Upgrade
|
| EV/EBITDA Ratio | 19.14 | 18.10 | 21.17 | 11.49 | 28.43 | 11.22 | Upgrade
|
| EV/EBIT Ratio | - | - | - | 84.51 | - | 23.52 | Upgrade
|
| EV/FCF Ratio | 16.00 | 34.36 | - | 94.83 | - | 95.12 | Upgrade
|
| Debt / Equity Ratio | 1.01 | 2.55 | 1.52 | 1.07 | 1.21 | 0.96 | Upgrade
|
| Debt / EBITDA Ratio | 4.44 | 9.88 | 10.36 | 4.42 | 11.13 | 3.14 | Upgrade
|
| Debt / FCF Ratio | 3.71 | 19.11 | - | 36.60 | - | 26.59 | Upgrade
|
| Net Debt / Equity Ratio | 0.93 | 2.34 | 1.35 | 0.68 | 1.01 | 0.58 | Upgrade
|
| Net Debt / EBITDA Ratio | 4.15 | 9.26 | 9.32 | 2.82 | 9.34 | 1.90 | Upgrade
|
| Net Debt / FCF Ratio | 3.43 | 17.58 | -2.61 | 23.30 | -4.23 | 16.13 | Upgrade
|
| Asset Turnover | 0.46 | 0.51 | 0.59 | 0.55 | 0.47 | 0.53 | Upgrade
|
| Inventory Turnover | 4.64 | 5.54 | 5.44 | 5.08 | 5.28 | 4.86 | Upgrade
|
| Quick Ratio | 0.11 | 0.11 | 0.14 | 0.55 | 0.24 | 0.59 | Upgrade
|
| Current Ratio | 0.40 | 0.28 | 0.36 | 0.92 | 0.55 | 0.89 | Upgrade
|
| Return on Equity (ROE) | -39.31% | -54.65% | -12.58% | -24.05% | -19.11% | 11.12% | Upgrade
|
| Return on Assets (ROA) | -1.63% | -2.39% | -1.65% | 0.80% | -1.88% | 4.38% | Upgrade
|
| Return on Invested Capital (ROIC) | -3.92% | -5.29% | -3.75% | 1.77% | -4.13% | 9.61% | Upgrade
|
| Return on Capital Employed (ROCE) | -4.60% | -8.50% | -4.60% | 1.90% | -4.90% | 9.30% | Upgrade
|
| Earnings Yield | -10.92% | -35.65% | -7.05% | -8.85% | -9.30% | 3.99% | Upgrade
|
| FCF Yield | 7.77% | 6.34% | -27.70% | 1.47% | -11.74% | 1.26% | Upgrade
|
| Dividend Yield | - | - | - | - | - | 0.93% | Upgrade
|
| Payout Ratio | - | - | - | - | - | 50.28% | Upgrade
|
| Buyback Yield / Dilution | -10.55% | -0.55% | -1.66% | -12.49% | 0.46% | -0.63% | Upgrade
|
| Total Shareholder Return | -10.55% | -0.55% | -1.66% | -12.49% | 0.46% | 0.30% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.